Showing results (611-620 of 706) with videos related to

Sort By:
Pageof 71
Leukemia|March 16, 2011
A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete responseJ M Brandwein, D W Hedley, S Chow, et al.
Cardiovascular and Interventional Radiology|September 27, 2024
Comparison of Chemotherapy Combined with Percutaneous Electroporation and Chemotherapy Alone in the Management of Locally Advanced Gallbladder Carcinoma (GBC): A Study ProtocolN Kalra, H Bhujade, A Baloji, et al.
Scientific Reports|February 23, 2017
Ruthenium based metallopolymer grafted reduced graphene oxide as a new hybrid solar light harvester in polymer solar cellsR Vinoth, S Ganesh Babu, Vishal Bharti, et al.
Clinical Radiology|December 3, 2019
Detection and localisation of hip fractures on anteroposterior radiographs with artificial intelligence: proof of conceptJ S Yu, S M Yu, B S Erdal, et al.
Academic Radiology|April 5, 2023
Radiologist-Trained AI Model for Identifying Suboptimal Chest-RadiographsGiridhar Dasegowda, Bernardo C Bizzo, Reya V Gupta, et al.
Oncotarget|April 15, 2015
Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancersVaishali Pannu, Karuna Mittal, Guilherme Cantuaria, et al.
Cell Death & Disease|June 15, 2012
Acute hypoxia induces apoptosis of pancreatic β-cell by activation of the unfolded protein response and upregulation of CHOPX Zheng, X Zheng, X Wang, et al.
Plos Medicine|April 3, 2019
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimizationNatasha Strydom, Sneha V Gupta, William S Fox, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial CarcinomaPetros Grivas, Lesli A Kiedrowski, Guru P Sonpavde, et al.
Eye (London, England)|November 26, 2016
Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatmentE Al Kahtani, Z Xu, S Al Rashaed, et al.
Pageof 71